Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
Journal of Clinical Medicine|June 26, 2026
Fusion of Clinical and Deep Learning Features for Predicting Pembrolizumab Monotherapy Response in Advanced Non-Small Cell Lung CancerLiton Devnath, Ian Janzen, Cheryl Ho, et al.
Lung Cancer (Amsterdam, Netherlands)|January 10, 2012
Erlotinib or best supportive care for third-line treatment of advanced non-small-cell lung cancer: a real-world cost-effectiveness analysisIan Cromwell, Kimberly van der Hoek, Suzanne C Malfair Taylor, et al.
Lung Cancer (Amsterdam, Netherlands)|December 3, 2014
Referral patterns in advanced non-small cell lung cancer: impact on delivery of treatment and survival in a contemporary population based cohortKrista Noonan, King Mong Tong, Janessa Laskin, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 4, 2021
Mapping childcare support for patients at a sample of North American hospitals and cancer centers: an environmental scanKatherine Preston, Mackenzie MacDonald, Meredith Giuliani, et al.
Lung Cancer (Amsterdam, Netherlands)|July 20, 2019
Immune checkpoint-inhibitors and chemoradiation in stage III unresectable non-small cell lung cancerBarbara Melosky, Rosalyn Juergens, Deanna McLeod, et al.
Future Oncology (London, England)|April 26, 2018
Bevacizumab biosimilars: scientific justification for extrapolation of indicationsBarbara Melosky, David A Reardon, Andrew B Nixon, et al.
Current Oncology (Toronto, Ont.)|August 25, 2023
Real-World Clinical Outcomes for Patients with <i>EGFR</i> and <i>HER2</i> Exon 20 Insertion-Mutated Non-Small-Cell Lung CancerKelly Li, Ian Bosdet, Stephen Yip, et al.
Lung Cancer (Amsterdam, Netherlands)|March 7, 2024
Outcomes of patients with advanced epithelial growth factor receptor mutant lung cancer treated with first-line osimertinib who would not have met the eligibility criteria for the FLAURA clinical trialJ Connor Wells, Monica M Mullin, Cheryl Ho, et al.
Journal of Oncology Practice|September 22, 2010
Impact of irinotecan and oxaliplatin on overall survival in patients with metastatic colorectal cancer: a population-based studyHoward J Lim, Sharlene Gill, Caroline Speers, et al.
Current Oncology (Toronto, Ont.)|October 27, 2022
Improving Time-to-Treatment for Advanced Non-Small Cell Lung Cancer Patients through Faster Single Gene EGFR Testing Using the Idylla™ EGFR Testing PlatformNorbert Banyi, Deepu Alex, Curtis Hughesman, et al.
Pageof 8